Notice of NIDCD Participation in RFA-EY-25-001, "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)"
Notice Number:
NOT-DC-25-021

Key Dates

Release Date:

December 18, 2024

Related Announcements

  • December 9, 2024 - BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed). See NOFO RFA-EY-25-001.

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Deafness and Other Communication Disorders (NIDCD) will participate in RFA-EY-25-001, "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)" effective January 6, 2025. 

The following text has been added to reflect NIDCD's participation:

Part 1. Overview Information

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

Assistance Listing Number(s)

93.867, 93.213, 93.866, 93.173, 93.242, 93.865, 93.273

All the other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Merav Sabri, PhD
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-827-0908
Email: [email protected]